Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
Clinical trial NCT00230178 · COMPLETED
Trial details
- NCT number
- NCT00230178
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2007-12-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.